Hand Scleroderma Experience Survey for People With Systemic Sclerosis
Part of Skin clinical trials.
This study is testing a new scale to measure what it's like to live with hand problems caused by systemic sclerosis (scleroderma). By answering questions about your daily hand function, you can help doctors better understand your experience and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of systemic sclerosis (scleroderma) from a rheumatologist.
- You are 18 years old or older.
- You do not have any neurological disease that affects your hand function, such as a stroke or nerve injury.
- You do not have any bone or joint problems that affect your hand or arm function, and you have not had orthopedic surgery.
- You speak and understand Turkish fluently.
- You do not have a psychiatric condition that makes it hard for you to cooperate with study tasks.
- You do not have heart failure or lung disease that limits your daily activities.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a simple 6-minute pegboard ring test to check how well your hands work. It aims to understand hand function in scleroderma and may help find new ways to track your health.
This study looks at hand function and disability in people with systemic sclerosis who have digital ulcers. It aims to understand how these ulcers affect daily hand use.
This study is adapting a questionnaire to measure how scleroderma affects your daily life. Your responses will help make the tool more useful for Turkish-speaking patients.
This study looks at how scleroderma affects physical performance and daily function in children and adults. It aims to understand the impact of the disease on movement and everyday activities.
This trial looks at how systemic sclerosis affects daily function and mental well-being, including social and emotional factors. It may help patients understand their condition better.
This study compares skin samples from people with scleroderma and healthy volunteers to understand what goes wrong in the skin. It may help researchers find new treatment targets.
Hear when a new Systemic Sclerosis (SSc) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.